SIX Financial Information

Enter Ticker Symbol:

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Kestra Medical Technologies, Ltd. (KMTS : NSDQ)

• Company Description

Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies. Kestra Medical Technologies, Ltd. is based in KIRKLAND, Wash.
Number of Employees: 330

• Price / Volume Information

Yesterday's Closing Price: $26.92 Daily Weekly Monthly

20 Day Moving Average: 215,084 shares

Shares Outstanding: 58.35 (millions)

Market Capitalization: $1,570.76 (millions)

Beta:

52 Week High: $30.00

52 Week Low: $13.25

Short Interest Ratio:

% Price Change % Price Change Relative to S&P 500

4 Week 17.15% 19.00%

12 Week 7.72% 3.04%

Year To Date 1.51% 3.74%

• Address & Contact Information

Street Address Phone / Fax Email Address Web URL

3933 Lake Washington Blvd NE Suite 200
-
Kirkland,WA 98033
USA ph: 425-279-8002
fax: - investor.relations@kestramedical.com http://www.kestramedical.com

• General Corporate Information

Officers

Brian Webster - President and Chief Executive Officer
Jeff Schwartz - Chairman
Vaseem Mahboob - Chief Financial Officer
Traci Umberger - General Counsel; Chief Administrative Officer and
Christopher Gordon - Director

Peer Information

Kestra Medical Technologies, Ltd. (BJCT)
Kestra Medical Technologies, Ltd. (CADMQ)
Kestra Medical Technologies, Ltd. (APNO)
Kestra Medical Technologies, Ltd. (UPDC)
Kestra Medical Technologies, Ltd. (IMTIQ)
Kestra Medical Technologies, Ltd. (CYGN)

Industry / Sector / Ticker Info

Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: G52441105
SIC: 3841

Fiscal Year

Fiscal Year End: April
Last Reported Quarter: 10/01/25
Next Expected EPS Date: -

Share - Related Items

Shares Outstanding: 58.35
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $1,570.76 (millions)

• EPS Information    • Dividend Information

Analyst Coverage: No Dividend Yield: 0.00%

Current Fiscal Quarter EPS Consensus Estimate: $-0.57 Indicated Annual Dividend: $0.00

Current Fiscal Year EPS Consensus Estimate: $-2.32 Payout Ratio:

Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:

Estmated Long-Term EPS Growth Rate: 30.21% Last Dividend Paid: NA - $0.00

Next EPS Report Date: -

• Fundamental Ratios

P/E

Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -

Price Ratios

Price/Book: 8.44
Price/Cash Flow: -
Price / Sales: -

EPS Growth

vs. Year Ago Period: -%
vs. Previous Quarter: -34.78%

Sales Growth

vs. Year Ago Period: 53.40%
vs. Previous Quarter: 16.49%

ROE

01/31/26 - -
10/31/25 - -74.86
07/31/25 - -94.76

ROA

01/31/26 - -
10/31/25 - -51.25
07/31/25 - -65.68

Current Ratio

01/31/26 - -
10/31/25 - 5.47
07/31/25 - 6.84

Quick Ratio

01/31/26 - -
10/31/25 - 5.47
07/31/25 - 6.84

Operating Margin

01/31/26 - -
10/31/25 - -
07/31/25 - -

Net Margin

01/31/26 - -
10/31/25 - -
07/31/25 - -

Pre-Tax Margin

01/31/26 - -
10/31/25 - -221.90
07/31/25 - -232.21

Book Value

01/31/26 - -
10/31/25 - 3.19
07/31/25 - 3.59

Inventory Turnover

01/31/26 - -
10/31/25 - -
07/31/25 - -

Debt-to-Equity

01/31/26 - -
10/31/25 - 0.26
07/31/25 - 0.23

Debt-to-Capital

01/31/26 - -
10/31/25 - 20.33
07/31/25 - 18.39

Powered by Zacks Investment Research ©